Moreover, multivariate analysis identified positive CD79B expression as an independent predictor of non-response to R-CHOP therapy (OR = 9.72).<h4>Conclusion</h4>CD79B expression was independently associated with a poor response to R-CHOP therapy in non-GCB DLBCL. This evidence concerns the gene CD79B and diffuse large B-cell lymphoma.